HOME >> BIOLOGY >> NEWS
The amendment to the law on green Genetic Engineering inhibits innovation and research in Germany

This release is also available in German.

The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) sees the draft amendment to the Genetic Engineering Act as a restriction on innovation and research in Germany. If the amendment were to be passed in its current form it runs the risk, in the opinion of the DFG, of putting German researchers at a considerable disadvantage on the international playing field. This is the key theme of the statement on the law on genetic engineering recently released by the DFG.

The DFG primarily opposes three aspects of the draft amendment. For instance, the draft put forward by the German federal government assumes that a particular risk is automatically attached to the introduction of genetically modified organisms (GMOs). In the opinion of the DFG this assumption is not backed up by experimental data.

The inappropriate risk assessment leads to increased red tape and hampers the transfer of the findings of basic research to economically viable processes and products. The draft amendment also intends to hold users of genetically modified organisms responsible for "intrusion" by GMOs into conventionally or ecologically produced seed. However, it is not possible in principle to prevent such cross breeding of genetically modified organisms. If the liability proposed in the amendment is enforced, research involving genetically modified organisms or their release will barely be possible in Germany any longer.

Thirdly, the DFG is against the planned splitting of the Central Commission for Biological Safety into two committees and the inclusion of members who do not have relevant technical expertise. The DFG does not perceive a need for new boards, new bureaucratic regulations or additional authorities.

The envisaged establishment of a federal register for recording the location of GMOs and registers for each of the 16 st
'"/>

Contact: Prof. Dr. Jrg Hacker
j.hacker@mail.uni-wuerzburg.de
49-0-9131-31-2575
Deutsche Forschungsgemeinschaft
6-Jul-2004


Page: 1 2

Related biology news :

1. Plants will not save us from greenhouse gases
2. Environmental decontamination, greenhouse gases, and the genome of a methane-loving bacterium
3. Spring through fall, cities are greener longer than neighboring rural regions
4. Urban heat islands make cities greener
5. Carnegie Mellon University hosts ACS-PRF summer school on green chemistry
6. New space-borne instrument to track greenhouse gases, ozone destroyers, and other pollutants
7. UK small firms pay lip service to green issues
8. Continents played key role in collapse and regeneration of Earths early greenhouse, geologists say
9. White tea beats green tea in fighting germs
10. Improved crop production and fewer greenhouse gases
11. Emerging frontiers genomics grant for blue-green bacteria

Post Your Comments:
(Date:8/26/2015)... 26, 2015 The report "Multi-Factor Authentication ... Factor), Application (Travel & Immigration, Government, Banking, Defense, Commercial ... to 2020", published by MarketsandMarkets, Multi-Factor Authentication Market is ... at a CAGR of 17.7% between 2015 and 2020. ... igures spread through 169 P ...
(Date:8/24/2015)... CAPE TOWN, South Africa , August 24, 2015 /PRNewswire/ ... awarded Germany ,s largest biometrics manufacturer DERMALOG ... with the "2015 African Biometrics Company of the ... installation in Nigeria .   ... ) and http://www.presseportal.de/nr/8896 - On Thursday ...
(Date:8/20/2015)... , Aug. 20, 2015 The wearable ... that are active and healthy. However, wearable technology ... hospital environment to help improve diagnostic capabilities and ... from the Wearable Technologies Conference 2015 , ... applications for wearables in healthcare.    ...
Breaking Biology News(10 mins):Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 2Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 3Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 4Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 5Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 2Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 3Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3
(Date:8/27/2015)... ... August 27, 2015 , ... Inc. Magazine released its annual ... Solutions as number 1,361 in growth for the three years through 2014. Being named ... fastest-growing privately held organizations in the country. , “We are thrilled to make ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... recently presented new data on the relationship of genetics and hypertension at the ... on Heart Disease in Vancouver, British Columbia, Canada. The event, which boasts an ...
(Date:8/26/2015)... , Aug. 26, 2015  Roka Bioscience, Inc. (NASDAQ: ... providing advanced testing solutions for the detection of foodborne ... present at the Sidoti & Company Emerging Growth Conference ... be held at the New York Marriott Marquis. ... be available through the investor relations section of Roka ...
(Date:8/26/2015)... 26, 2015  Platform therapeutic company Symic Biomedical, ... a $1.5M Phase II SBIR grant from the ... its therapeutic agent to reduce arteriovenous fistula (AVF) ... stage renal disease (ESRD) patients undergoing hemodialysis. The ... Diabetes and Digestive and Kidney Diseases (NIDDK), will ...
Breaking Biology Technology:iLab Solutions Named to 2015 Inc. 5000 List 2iLab Solutions Named to 2015 Inc. 5000 List 3Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 2Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 3Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3
Cached News: